Hancock Jaffe Laboratories develops bioprosthetic devices for cardiovascular surgeries.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Irvine
State: California
Zip:
Country: United States
Hancock Jaffe Laboratories develops life-enhancing bioprosthetic devices and technologies intended to achieve unparalleled outcomes for patients with debilitating cardiovascular diseases. Each device is designed to allow vascular and cardiothoracic surgeons to achieve maximum effectiveness while greatly reducing the time and complexity of current procedures in concert with a commitment to efficient health care delivery. Founded in 1987 by Norman Jaffe, Hancock Jaffe Laboratories is headquartered in Irvine, California.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
5/31/2018
Ticker Symbol:
HJLI
IPO Price:
$5/share
Amount Raised:
$8M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2021 | Post-IPO Equity | 1 | $20M |
Perceptive Advisors Perceptive Advisors |
5/2019 | Post-IPO Equity | $2.7M | 2/2021 | Post-IPO Equity | $41.4M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|